Update on Cystic Fibrosis

E-ISSN： 2055-2335|34|2|125-127

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.34, Iss.2, 2004-06, pp. : 125-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Toward the pharmacogenomics of cystic fibrosis – an update

By Sangiuolo Federica D’Apice Maria Rosaria Gambardella Stefano Di Daniele Nicola Novelli Giuseppe

Pharmacogenomics, Vol. 5, Iss. 7, 2004-10 ,pp. : 861-878

Future Medicine

Access to resources Recommend Favorite

Drug Disposition in Cystic Fibrosis

By Rey E. Tréluyer J-M. Pons G.

Clinical Pharmacokinetics, Vol. 35, Iss. 4, 1998-10 ,pp. : 313-329

Adis International

Access to resources Recommend Favorite

Nebulized Antibiotics in Cystic Fibrosis

By Sermetgaudelus I.

Pediatric Drugs, Vol. 4, Iss. 7, 2002-01 ,pp. : 455-467

Adis International

Access to resources Recommend Favorite

Non-cystic fibrosis bronchiectasis

By Murray Maeve P Hill Adam T

Clinical Medicine, Vol. 9, Iss. 2, 2009-04 ,pp. : 164-169

Royal College Of Physicians

Access to resources Recommend Favorite

Na + in cystic fibrosis: is it important?

By Knox A.J. Peckham D.G.

Trends in Pharmacological Sciences, Vol. 16, Iss. 4, 1995-04 ,pp. : 120-121

Elsevier

Access to resources Recommend Favorite